12 minute read

May 9, 2024

PRMT5 Target Review: The Next "First-in-Class" Epigenetic Drug?

Authors:

Ivy Hung,

Dennis C. Koester

Reviewers:

Brendan Parr,

Eric Newcomb

Editor:

Other articles you may be interested in